Extremity Innovations, Inc. Receives CE Mark for InnoPad
Summary
InnoPad™ is Extremity Innovations’ first product to gain regulatory clearances and will help establish the two-year-old company as a leader in providing simple, safe, innovative and economical solutions to the soft tissue field.The company’s first product, InnoPad™, addresses the devastating and debilitating problem of foot ulcers in diabetic patients and will be introduced to the international market in 2008.### Bartlett, TN, November 15, 2008 --( PR.com )-- InnoPad™ is an injectable implant that is indicated for augmentation of the subdermal fat pad tissue of the plantar surface (bottom) of the foot.InnoPad™ brings to market the work of the late Sol W. Balkin, DPM, who dedicated more than forty years of his career to providing this innovative solution to patients showing signs of fat pad deterioration.InnoPad™ is Extremity Innovations’ first product to gain regulatory clearances and will help establish the two-year-old company as a leader in providing simple, safe, innovative and economical solutions to the soft tissue field.The company’s first product, InnoPad™, addresses the devastating and debilitating problem of foot ulcers in diabetic patients and will be introduced to the international market in 2008.